OVCA433人卵巢癌細(xì)胞、O 返回列表頁

舉報(bào) 評價(jià)

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號

品牌

廠商性質(zhì)生產(chǎn)商

所在地

在線詢價(jià) 加入對比查看聯(lián)系電話

更新時(shí)間：2025-02-11 23:46:01瀏覽次數(shù)：7次

聯(lián)系我時(shí)，請告知來自化工儀器網(wǎng)

同類優(yōu)質(zhì)產(chǎn)品更多>

NCI-H250人小細(xì)胞肺癌細(xì)

參考價(jià) 面議
SNU-719人胃癌細(xì)胞、SN

參考價(jià) 面議
HDLM-2人霍奇金淋巴瘤細(xì)胞

參考價(jià) 面議
MEG-01 人成巨核細(xì)胞白血

參考價(jià) 面議
KFB人腎成纖維細(xì)胞、KFB細(xì)

參考價(jià) 面議

產(chǎn)品分類品牌分類

細(xì)胞庫 / 細(xì)胞培養(yǎng): 細(xì)胞株 ATCC細(xì)胞原代細(xì)胞干細(xì)胞普通細(xì)胞

全部產(chǎn)品列表

產(chǎn)品簡介

OVCA433人卵巢癌細(xì)胞CatalogueNo

詳情介紹

OVCA433 人卵巢癌細(xì)胞
Catalogue No.: C1505
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

Item	Specifications
a T25 flask	2X10⁶
Manual	1 copy

initiated in or before Phase II. The development of CDx tests for emerging immunotherapies will be more complicated because they are not dependent on driver mutations in the drug target, the mechanism of action is often pleiotropic, and will require both protein and cell-based assays to evaluate the interaction of the tumor with the immune system. Consequently, we will need to develop new biomarker strategies for the development